AFP
NEO icon

Ausdal Financial Partners’s NeoGenomics NEO Stock Holding History

Ausdal Financial Partners’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-7,646
Closed -$60K – 739
2015
Q4 		$60K Buy
+7,646
New +$56K 0.03% 409

Other funds holding NEO

GE
General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

Ausdal Financial Partners's NEO Position: Q1 2016 in Review

Ausdal Financial Partners sold out of NeoGenomics (NEO) in Q1 2016, closing a stake of 7,646 shares — an estimated $60K sold.

Ausdal Financial Partners first reported a position in NEO in Q4 2015 and held it in 1 quarter. The position peaked at $60K in Q4 2015. 119 funds tracked by Wall St. Rank hold NEO as of Q1 2016.

  • Ausdal Financial Partners reported no remaining NeoGenomics position as of Q1 2016 after selling out during the quarter.
  • Ausdal Financial Partners sold 7,646 NeoGenomics shares in Q1 2016, an estimated $60K.
  • Ausdal Financial Partners first reported a position in NeoGenomics in Q4 2015 and held it in 1 quarter.
  • Ausdal Financial Partners's NeoGenomics position peaked at $60K in Q4 2015.
  • 119 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2016.

Based on Ausdal Financial Partners's 13F filing for Q1 2016, filed 5 May 2016.